Furnishings, Fixtures & Appliances
Compare Stocks
4 / 10Stock Comparison
IRBT vs TTI vs NVCR vs NCSM
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Equipment & Services
Medical - Instruments & Supplies
Oil & Gas Equipment & Services
IRBT vs TTI vs NVCR vs NCSM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Furnishings, Fixtures & Appliances | Oil & Gas Equipment & Services | Medical - Instruments & Supplies | Oil & Gas Equipment & Services |
| Market Cap | $2M | $1.32B | $1.92B | $105M |
| Revenue (TTM) | $547M | $630M | $674M | $180M |
| Net Income (TTM) | $-209M | $7M | $-173M | $19M |
| Gross Margin | 22.0% | 24.6% | 75.2% | 36.7% |
| Operating Margin | -29.5% | 8.4% | -27.2% | 5.2% |
| Forward P/E | — | 37.9x | — | 11.8x |
| Total Debt | $227M | $263M | $290M | $13M |
| Cash & Equiv. | $134M | $45M | $103M | $37M |
IRBT vs TTI vs NVCR vs NCSM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Feb 26 | Return |
|---|---|---|---|
| iRobot Corporation (IRBT) | 100 | 0.1 | -99.9% |
| TETRA Technologies,… (TTI) | 100 | 3454.5 | +3354.5% |
| NovoCure Limited (NVCR) | 100 | 18.4 | -81.6% |
| NCS Multistage Hold… (NCSM) | 100 | 383.5 | +283.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IRBT vs TTI vs NVCR vs NCSM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IRBT plays a supporting role in this comparison — it may shine differently against other peers.
TTI is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 96.4% 10Y total return vs NVCR's 30.3%
- +246.3% vs IRBT's -97.7%
NVCR lags the leaders in this set but could rank higher in a more targeted comparison.
NCSM carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.28
- Rev growth 13.6%, EPS growth 239.2%, 3Y rev CAGR 5.9%
- Lower volatility, beta 0.28, Low D/E 9.0%, current ratio 4.27x
- Beta 0.28, current ratio 4.27x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.6% revenue growth vs IRBT's -23.4% | |
| Value | Better valuation composite | |
| Quality / Margins | 10.8% margin vs IRBT's -38.2% | |
| Stability / Safety | Beta 0.28 vs IRBT's 5.21, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +246.3% vs IRBT's -97.7% | |
| Efficiency (ROA) | 11.4% ROA vs IRBT's -43.3%, ROIC 7.9% vs -38.6% |
IRBT vs TTI vs NVCR vs NCSM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IRBT vs TTI vs NVCR vs NCSM — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NCSM leads in 2 of 6 categories
TTI leads 1 • IRBT leads 0 • NVCR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — TTI and NVCR and NCSM each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NVCR is the larger business by revenue, generating $674M annually — 3.8x NCSM's $180M. NCSM is the more profitable business, keeping 10.8% of every revenue dollar as net income compared to IRBT's -38.2%. On growth, NVCR holds the edge at +12.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $547M | $630M | $674M | $180M |
| EBITDAEarnings before interest/tax | -$151M | $90M | -$165M | $15M |
| Net IncomeAfter-tax profit | -$209M | $7M | -$173M | $19M |
| Free Cash FlowCash after capex | -$107M | $3M | -$48M | $24M |
| Gross MarginGross profit ÷ Revenue | +22.0% | +24.6% | +75.2% | +36.7% |
| Operating MarginEBIT ÷ Revenue | -29.5% | +8.4% | -27.2% | +5.2% |
| Net MarginNet income ÷ Revenue | -38.2% | +1.2% | -25.7% | +10.8% |
| FCF MarginFCF ÷ Revenue | -19.6% | +0.4% | -7.1% | +13.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -24.6% | -0.6% | +12.3% | -8.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -195.2% | +100.0% | -100.0% | -109.3% |
Valuation Metrics
NCSM leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 4.6x trailing earnings, NCSM trades at a 99% valuation discount to TTI's 439.9x P/E. On an enterprise value basis, NCSM's 4.6x EV/EBITDA is more attractive than TTI's 15.9x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $2M | $1.3B | $1.9B | $105M |
| Enterprise ValueMkt cap + debt − cash | $95M | $1.5B | $2.1B | $81M |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | 439.86x | -13.80x | 4.60x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 37.91x | — | 11.82x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 15.93x | — | 4.57x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 2.09x | 2.92x | 0.57x |
| Price / BookPrice ÷ Book value/share | 0.03x | 4.67x | 5.51x | 0.76x |
| Price / FCFMarket cap ÷ FCF | — | 67.62x | — | 4.98x |
Profitability & Efficiency
NCSM leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
NCSM delivers a 14.4% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-113 for IRBT. NCSM carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRBT's 3.71x. On the Piotroski fundamental quality scale (0–9), NCSM scores 6/9 vs IRBT's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -112.9% | +2.5% | -50.8% | +14.4% |
| ROA (TTM)Return on assets | -43.3% | +1.1% | -16.5% | +11.4% |
| ROICReturn on invested capital | -38.6% | +9.5% | -16.4% | +7.9% |
| ROCEReturn on capital employed | -27.7% | +9.7% | -28.9% | +8.4% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 5 | 6 |
| Debt / EquityFinancial leverage | 3.71x | 0.93x | 0.85x | 0.09x |
| Net DebtTotal debt minus cash | $93M | $218M | $187M | -$24M |
| Cash & Equiv.Liquid assets | $134M | $45M | $103M | $37M |
| Total DebtShort + long-term debt | $227M | $263M | $290M | $13M |
| Interest CoverageEBIT ÷ Interest expense | -3.36x | 2.96x | -96.80x | 28.21x |
Total Returns (Dividends Reinvested)
TTI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TTI five years ago would be worth $28,304 today (with dividends reinvested), compared to $6 for IRBT. Over the past 12 months, TTI leads with a +246.3% total return vs IRBT's -97.7%. The 3-year compound annual growth rate (CAGR) favors TTI at 48.9% vs IRBT's -88.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -55.0% | -0.3% | +28.3% | +0.5% |
| 1-Year ReturnPast 12 months | -97.7% | +246.3% | +1.1% | +28.1% |
| 3-Year ReturnCumulative with dividends | -99.9% | +229.9% | -75.7% | +104.9% |
| 5-Year ReturnCumulative with dividends | -99.9% | +183.0% | -91.3% | +51.4% |
| 10-Year ReturnCumulative with dividends | -99.9% | +96.4% | +30.3% | -90.0% |
| CAGR (3Y)Annualised 3-year return | -88.8% | +48.9% | -37.6% | +27.0% |
Risk & Volatility
Evenly matched — NVCR and NCSM each lead in 1 of 2 comparable metrics.
Risk & Volatility
NCSM is the less volatile stock with a 0.28 beta — it tends to amplify market swings less than IRBT's 5.21 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVCR currently trades 83.9% from its 52-week high vs IRBT's 0.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 5.31x | 1.44x | 2.15x | 0.16x |
| 52-Week HighHighest price in past year | $6.10 | $12.54 | $20.06 | $87.36 |
| 52-Week LowLowest price in past year | $0.04 | $2.63 | $9.82 | $28.64 |
| % of 52W HighCurrent price vs 52-week peak | +0.9% | +77.9% | +83.9% | +45.6% |
| RSI (14)Momentum oscillator 0–100 | 33.9 | 63.6 | 69.8 | 27.8 |
| Avg Volume (50D)Average daily shares traded | 0 | 1.8M | 1.5M | 38K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: TTI as "Buy", NVCR as "Buy". Consensus price targets imply 99.0% upside for NVCR (target: $34) vs 25.4% for TTI (target: $12).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | — |
| Price TargetConsensus 12-month target | — | $12.25 | $33.50 | — |
| # AnalystsCovering analysts | — | 31 | 15 | — |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +0.3% |
NCSM leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). TTI leads in 1 (Total Returns). 2 tied.
IRBT vs TTI vs NVCR vs NCSM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IRBT or TTI or NVCR or NCSM a better buy right now?
For growth investors, NCS Multistage Holdings, Inc.
(NCSM) is the stronger pick with 13. 6% revenue growth year-over-year, versus -23. 4% for iRobot Corporation (IRBT). NCS Multistage Holdings, Inc. (NCSM) offers the better valuation at 4. 6x trailing P/E (11. 8x forward), making it the more compelling value choice. Analysts rate TETRA Technologies, Inc. (TTI) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IRBT or TTI or NVCR or NCSM?
On trailing P/E, NCS Multistage Holdings, Inc.
(NCSM) is the cheapest at 4. 6x versus TETRA Technologies, Inc. at 439. 9x. On forward P/E, NCS Multistage Holdings, Inc. is actually cheaper at 11. 8x.
03Which is the better long-term investment — IRBT or TTI or NVCR or NCSM?
Over the past 5 years, TETRA Technologies, Inc.
(TTI) delivered a total return of +183. 0%, compared to -99. 9% for iRobot Corporation (IRBT). Over 10 years, the gap is even starker: TTI returned +96. 6% versus IRBT's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IRBT or TTI or NVCR or NCSM?
By beta (market sensitivity over 5 years), NCS Multistage Holdings, Inc.
(NCSM) is the lower-risk stock at 0. 16β versus iRobot Corporation's 5. 31β — meaning IRBT is approximately 3185% more volatile than NCSM relative to the S&P 500. On balance sheet safety, NCS Multistage Holdings, Inc. (NCSM) carries a lower debt/equity ratio of 9% versus 4% for iRobot Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — IRBT or TTI or NVCR or NCSM?
By revenue growth (latest reported year), NCS Multistage Holdings, Inc.
(NCSM) is pulling ahead at 13. 6% versus -23. 4% for iRobot Corporation (IRBT). On earnings-per-share growth, the picture is similar: NCS Multistage Holdings, Inc. grew EPS 239. 2% year-over-year, compared to -97. 3% for TETRA Technologies, Inc.. Over a 3-year CAGR, NVCR leads at 6. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IRBT or TTI or NVCR or NCSM?
NCS Multistage Holdings, Inc.
(NCSM) is the more profitable company, earning 12. 9% net margin versus -21. 3% for iRobot Corporation — meaning it keeps 12. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TTI leads at 9. 4% versus -23. 5% for NVCR. At the gross margin level — before operating expenses — NVCR leads at 74. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IRBT or TTI or NVCR or NCSM more undervalued right now?
On forward earnings alone, NCS Multistage Holdings, Inc.
(NCSM) trades at 11. 8x forward P/E versus 37. 9x for TETRA Technologies, Inc. — 26. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NVCR: 99. 0% to $33. 50.
08Which pays a better dividend — IRBT or TTI or NVCR or NCSM?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is IRBT or TTI or NVCR or NCSM better for a retirement portfolio?
For long-horizon retirement investors, NCS Multistage Holdings, Inc.
(NCSM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 16)). iRobot Corporation (IRBT) carries a higher beta of 5. 31 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NCSM: -89. 9%, IRBT: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IRBT and TTI and NVCR and NCSM?
These companies operate in different sectors (IRBT (Consumer Cyclical) and TTI (Energy) and NVCR (Healthcare) and NCSM (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IRBT is a small-cap quality compounder stock; TTI is a small-cap quality compounder stock; NVCR is a small-cap quality compounder stock; NCSM is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.